AI Bias Analysis
4 models · Takes ~15 seconds
“They don’t want this kind of scrutiny”: Why Dr. Glaucomflecken is getting involved in protests over an Oregon hospital system’s emergency department.
Source
Stat News
Opens original article in a new tab
Cell and gene therapy makers met in Rome to discuss the field's outlook in Europe. One main topic of conversation: the FDA.
Policy recommendations in OpenAI's blueprint for unlocking AI’s potential to change health care are reasonable, but also self-serving, experts say.
The psychedelics field is getting what it has long wanted. Now it has to step up.
Ambiguous loss is at the heart of the dementia illness experience.
